Tislelizumab Combined with Chemotherapy and All Trans Retinoic Acid for Locally Advanced or Metastatic Esophageal Squamous Cell Carcinoma
Clinical trial NCT06703047 · NOT_YET_RECRUITING
Trial details
- NCT number
- NCT06703047
- Sponsor
- Fudan University
- Status
- NOT_YET_RECRUITING
- Phase
- Phase 2
- Study type
- INTERVENTIONAL
- Start date
- 2024-11-20
- Primary completion
- 2029-11-20
- Enrollment
- 180
Track trials programmatically
Sponsors, conditions and status changes through the Atlas API.